BioKier

About:

BioKier is an early-stage pharmaceutical company that develops drugs for diabetes and related disorders.

Top Investors: American Heart Association, Broadview Ventures

Description:

BioKier is an early-stage pharmaceutical company that develops drugs for diabetes and related disorders. It offers oral pills for the treatment of type 2 diabetes, as well as for metabolic syndrome and obesity conditions. It was incorporated in 2008 and is based in Chapel Hill, North Carolina

Total Funding Amount:

$2.89M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Chapel Hill, North Carolina, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)biokier.com

Founders:

George Szewczyk, Roger Nolan

Number of Employees:

1-10

Last Funding Date:

2015-01-01

IPO Status:

Private

Industries: